Global Nano-drug Sales Market Report 2018

Publisher Name :
Date: 14-Jun-2018
No. of pages: 129
Inquire Before Buying

This report studies the global Nano-drug market status and forecast, categorizes the global Nano-drug market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

The global Nano-drug market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.

The major players covered in this report

- Merck

- Pfizer

- Novartis

- Abbott

- GlaxoSmithKline

- Roche

- Sanofi

- Eli Lilly

- Astrazeneca

- Johnson & Johnson

- Celgene

- Novavax

- Stryker

- Gilead Sciences

- OSI Pharmaceuticals

- Kadmon Pharmaceuticals

- Samyang Biopharm

- Mitsubishi Pharma

- Kaken Pharmaceutical

- Selecta Biosciences

- Par Pharmaceutical

- Cerulean Pharma

- Navidea Biopharmaceuticals

- Lummy

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

- United States

- Europe

- China

- Japan

- Southeast Asia

- India

We can also provide the customized separate regional or country-level reports, for the following regions:

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Rest of Asia-Pacific

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- - Rest of Europe

- Central & South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Saudi Arabia

- - Turkey

- - Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Liposomes

- Polymeric Micelles

- Solid lipid Nanoparticles

- Microemulsion and Nanoemulsion

- Nanosuspension

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

- Cancer and Tumors

- Autoimmune Disorders

The study objectives of this report are:

- To analyze and study the global Nano-drug sales, value, status (2013-2017) and forecast (2018-2025);

- To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.

- Focuses on the key Nano-drug players, to study the sales, value, market share and development plans in future.

- Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.

- To define, describe and forecast the market by type, application and region.

- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

- To identify significant trends and factors driving or inhibiting the market growth.

- To analyze the opportunities in the market for stakeholders by identifying the high growth segments.

- To strategically analyze each submarket with respect to individual growth trend and their contribution to the market

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

- To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Nano-drug are as follows:

- History Year: 2013-2017

- Base Year: 2017

- Estimated Year: 2018

- Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Nano-drug Manufacturers

Nano-drug Distributors/Traders/Wholesalers

Nano-drug Subcomponent Manufacturers

Industry Association

Downstream Vendors

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Regional and country-level analysis of the Nano-drug market, by end-use.

Detailed analysis and profiles of additional market players.

Global Nano-drug Sales Market Report 2018

Table of Contents
Global Nano-drug Sales Market Report 2018
1 Nano-drug Market Overview
1.1 Product Overview and Scope of Nano-drug
1.2 Classification of Nano-drug by Product Category
1.2.1 Global Nano-drug Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Nano-drug Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Liposomes
1.2.4 Polymeric Micelles
1.2.5 Solid lipid Nanoparticles
1.2.6 Microemulsion and Nanoemulsion
1.2.7 Nanosuspension
1.3 Global Nano-drug Market by Application/End Users
1.3.1 Global Nano-drug Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Cancer and Tumors
1.3.2 Autoimmune Disorders
1.4 Global Nano-drug Market by Region
1.4.1 Global Nano-drug Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Nano-drug Status and Prospect (2013-2025)
1.4.3 Europe Nano-drug Status and Prospect (2013-2025)
1.4.4 China Nano-drug Status and Prospect (2013-2025)
1.4.5 Japan Nano-drug Status and Prospect (2013-2025)
1.4.6 Southeast Asia Nano-drug Status and Prospect (2013-2025)
1.4.7 India Nano-drug Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Nano-drug (2013-2025)
1.5.1 Global Nano-drug Sales and Growth Rate (2013-2025)
1.5.2 Global Nano-drug Revenue and Growth Rate (2013-2025)
2 Global Nano-drug Competition by Players/Suppliers, Type and Application
2.1 Global Nano-drug Market Competition by Players/Suppliers
2.1.1 Global Nano-drug Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Nano-drug Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Nano-drug (Volume and Value) by Type
2.2.1 Global Nano-drug Sales and Market Share by Type (2013-2018)
2.2.2 Global Nano-drug Revenue and Market Share by Type (2013-2018)
2.3 Global Nano-drug (Volume and Value) by Region
2.3.1 Global Nano-drug Sales and Market Share by Region (2013-2018)
2.3.2 Global Nano-drug Revenue and Market Share by Region (2013-2018)
2.4 Global Nano-drug (Volume) by Application
3 United States Nano-drug (Volume, Value and Sales Price)
3.1 United States Nano-drug Sales and Value (2013-2018)
3.1.1 United States Nano-drug Sales and Growth Rate (2013-2018)
3.1.2 United States Nano-drug Revenue and Growth Rate (2013-2018)
3.1.3 United States Nano-drug Sales Price Trend (2013-2018)
3.2 United States Nano-drug Sales Volume and Market Share by Players (2013-2018)
3.3 United States Nano-drug Sales Volume and Market Share by Type (2013-2018)
3.4 United States Nano-drug Sales Volume and Market Share by Application (2013-2018)
4 Europe Nano-drug (Volume, Value and Sales Price)
4.1 Europe Nano-drug Sales and Value (2013-2018)
4.1.1 Europe Nano-drug Sales and Growth Rate (2013-2018)
4.1.2 Europe Nano-drug Revenue and Growth Rate (2013-2018)
4.1.3 Europe Nano-drug Sales Price Trend (2013-2018)
4.2 Europe Nano-drug Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Nano-drug Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Nano-drug Sales Volume and Market Share by Application (2013-2018)
5 China Nano-drug (Volume, Value and Sales Price)
5.1 China Nano-drug Sales and Value (2013-2018)
5.1.1 China Nano-drug Sales and Growth Rate (2013-2018)
5.1.2 China Nano-drug Revenue and Growth Rate (2013-2018)
5.1.3 China Nano-drug Sales Price Trend (2013-2018)
5.2 China Nano-drug Sales Volume and Market Share by Players (2013-2018)
5.3 China Nano-drug Sales Volume and Market Share by Type (2013-2018)
5.4 China Nano-drug Sales Volume and Market Share by Application (2013-2018)
6 Japan Nano-drug (Volume, Value and Sales Price)
6.1 Japan Nano-drug Sales and Value (2013-2018)
6.1.1 Japan Nano-drug Sales and Growth Rate (2013-2018)
6.1.2 Japan Nano-drug Revenue and Growth Rate (2013-2018)
6.1.3 Japan Nano-drug Sales Price Trend (2013-2018)
6.2 Japan Nano-drug Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Nano-drug Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Nano-drug Sales Volume and Market Share by Application (2013-2018)
7 Southeast Asia Nano-drug (Volume, Value and Sales Price)
7.1 Southeast Asia Nano-drug Sales and Value (2013-2018)
7.1.1 Southeast Asia Nano-drug Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Nano-drug Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Nano-drug Sales Price Trend (2013-2018)
7.2 Southeast Asia Nano-drug Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Nano-drug Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Nano-drug Sales Volume and Market Share by Application (2013-2018)
8 India Nano-drug (Volume, Value and Sales Price)
8.1 India Nano-drug Sales and Value (2013-2018)
8.1.1 India Nano-drug Sales and Growth Rate (2013-2018)
8.1.2 India Nano-drug Revenue and Growth Rate (2013-2018)
8.1.3 India Nano-drug Sales Price Trend (2013-2018)
8.2 India Nano-drug Sales Volume and Market Share by Players (2013-2018)
8.3 India Nano-drug Sales Volume and Market Share by Type (2013-2018)
8.4 India Nano-drug Sales Volume and Market Share by Application (2013-2018)
9 Global Nano-drug Players/Suppliers Profiles and Sales Data
9.1 Merck
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Nano-drug Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Merck Nano-drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Pfizer
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Nano-drug Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Pfizer Nano-drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 Novartis
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Nano-drug Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Novartis Nano-drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Abbott
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Nano-drug Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Abbott Nano-drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 GlaxoSmithKline
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Nano-drug Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 GlaxoSmithKline Nano-drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Roche
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Nano-drug Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Roche Nano-drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Sanofi
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Nano-drug Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Sanofi Nano-drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 Eli Lilly
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Nano-drug Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Eli Lilly Nano-drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview
9.9 Astrazeneca
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Nano-drug Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Astrazeneca Nano-drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.9.4 Main Business/Business Overview
9.10 Johnson & Johnson
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Nano-drug Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Johnson & Johnson Nano-drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.10.4 Main Business/Business Overview
9.11 Celgene
9.12 Novavax
9.13 Stryker
9.14 Gilead Sciences
9.15 OSI Pharmaceuticals
9.16 Kadmon Pharmaceuticals
9.17 Samyang Biopharm
9.18 Mitsubishi Pharma
9.19 Kaken Pharmaceutical
9.20 Selecta Biosciences
9.21 Par Pharmaceutical
9.22 Cerulean Pharma
9.23 Navidea Biopharmaceuticals
9.24 Lummy
10 Nano-drug Maufacturing Cost Analysis
10.1 Nano-drug Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Nano-drug
10.3 Manufacturing Process Analysis of Nano-drug
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Nano-drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Nano-drug Major Manufacturers in 2017
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Nano-drug Market Forecast (2018-2025)
14.1 Global Nano-drug Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Nano-drug Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Nano-drug Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Nano-drug Price and Trend Forecast (2018-2025)
14.2 Global Nano-drug Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Nano-drug Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Nano-drug Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Nano-drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Nano-drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Nano-drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Nano-drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Nano-drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Nano-drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Nano-drug Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Nano-drug Sales Forecast by Type (2018-2025)
14.3.2 Global Nano-drug Revenue Forecast by Type (2018-2025)
14.3.3 Global Nano-drug Price Forecast by Type (2018-2025)
14.4 Global Nano-drug Sales Volume Forecast by Application (2018-2025)
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Nano-drug
Figure Global Nano-drug Sales Volume Comparison (K Doses) by Type (2013-2025)
Figure Global Nano-drug Sales Volume Market Share by Type (Product Category) in 2017
Figure Liposomes Product Picture
Figure Polymeric Micelles Product Picture
Figure Solid lipid Nanoparticles Product Picture
Figure Microemulsion and Nanoemulsion Product Picture
Figure Nanosuspension Product Picture
Figure Global Nano-drug Sales Comparison (K Doses) by Application (2013-2025)
Figure Global Sales Market Share of Nano-drug by Application in 2017
Figure Cancer and Tumors Examples
Table Key Downstream Customer in Cancer and Tumors
Figure Autoimmune Disorders Examples
Table Key Downstream Customer in Autoimmune Disorders
Figure Global Nano-drug Market Size (Million USD) by Regions (2013-2025)
Figure United States Nano-drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Nano-drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Nano-drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Nano-drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Nano-drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Nano-drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Nano-drug Sales Volume (K Doses) and Growth Rate (2013-2025)
Figure Global Nano-drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Nano-drug Sales Volume (K Doses) (2013-2018)
Table Global Nano-drug Sales (K Doses) of Key Players/Suppliers (2013-2018)
Table Global Nano-drug Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Nano-drug Sales Share by Players/Suppliers
Figure 2017 Nano-drug Sales Share by Players/Suppliers
Figure Global Nano-drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Nano-drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Nano-drug Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Nano-drug Revenue Share by Players
Table 2017 Global Nano-drug Revenue Share by Players
Table Global Nano-drug Sales (K Doses) and Market Share by Type (2013-2018)
Table Global Nano-drug Sales Share (K Doses) by Type (2013-2018)
Figure Sales Market Share of Nano-drug by Type (2013-2018)
Figure Global Nano-drug Sales Growth Rate by Type (2013-2018)
Table Global Nano-drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Nano-drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Nano-drug by Type (2013-2018)
Figure Global Nano-drug Revenue Growth Rate by Type (2013-2018)
Table Global Nano-drug Sales Volume (K Doses) and Market Share by Region (2013-2018)
Table Global Nano-drug Sales Share by Region (2013-2018)
Figure Sales Market Share of Nano-drug by Region (2013-2018)
Figure Global Nano-drug Sales Growth Rate by Region in 2017
Table Global Nano-drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Nano-drug Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Nano-drug by Region (2013-2018)
Figure Global Nano-drug Revenue Growth Rate by Region in 2017
Table Global Nano-drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Nano-drug Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Nano-drug by Region (2013-2018)
Figure Global Nano-drug Revenue Market Share by Region in 2017
Table Global Nano-drug Sales Volume (K Doses) and Market Share by Application (2013-2018)
Table Global Nano-drug Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Nano-drug by Application (2013-2018)
Figure Global Nano-drug Sales Market Share by Application (2013-2018)
Figure United States Nano-drug Sales (K Doses) and Growth Rate (2013-2018)
Figure United States Nano-drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Nano-drug Sales Price (USD/Dose) Trend (2013-2018)
Table United States Nano-drug Sales Volume (K Doses) by Players (2013-2018)
Table United States Nano-drug Sales Volume Market Share by Players (2013-2018)
Figure United States Nano-drug Sales Volume Market Share by Players in 2017
Table United States Nano-drug Sales Volume (K Doses) by Type (2013-2018)
Table United States Nano-drug Sales Volume Market Share by Type (2013-2018)
Figure United States Nano-drug Sales Volume Market Share by Type in 2017
Table United States Nano-drug Sales Volume (K Doses) by Application (2013-2018)
Table United States Nano-drug Sales Volume Market Share by Application (2013-2018)
Figure United States Nano-drug Sales Volume Market Share by Application in 2017
Figure Europe Nano-drug Sales (K Doses) and Growth Rate (2013-2018)
Figure Europe Nano-drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Nano-drug Sales Price (USD/Dose) Trend (2013-2018)
Table Europe Nano-drug Sales Volume (K Doses) by Players (2013-2018)
Table Europe Nano-drug Sales Volume Market Share by Players (2013-2018)
Figure Europe Nano-drug Sales Volume Market Share by Players in 2017
Table Europe Nano-drug Sales Volume (K Doses) by Type (2013-2018)
Table Europe Nano-drug Sales Volume Market Share by Type (2013-2018)
Figure Europe Nano-drug Sales Volume Market Share by Type in 2017
Table Europe Nano-drug Sales Volume (K Doses) by Application (2013-2018)
Table Europe Nano-drug Sales Volume Market Share by Application (2013-2018)
Figure Europe Nano-drug Sales Volume Market Share by Application in 2017
Figure China Nano-drug Sales (K Doses) and Growth Rate (2013-2018)
Figure China Nano-drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Nano-drug Sales Price (USD/Dose) Trend (2013-2018)
Table China Nano-drug Sales Volume (K Doses) by Players (2013-2018)
Table China Nano-drug Sales Volume Market Share by Players (2013-2018)
Figure China Nano-drug Sales Volume Market Share by Players in 2017
Table China Nano-drug Sales Volume (K Doses) by Type (2013-2018)
Table China Nano-drug Sales Volume Market Share by Type (2013-2018)
Figure China Nano-drug Sales Volume Market Share by Type in 2017
Table China Nano-drug Sales Volume (K Doses) by Application (2013-2018)
Table China Nano-drug Sales Volume Market Share by Application (2013-2018)
Figure China Nano-drug Sales Volume Market Share by Application in 2017
Figure Japan Nano-drug Sales (K Doses) and Growth Rate (2013-2018)
Figure Japan Nano-drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Nano-drug Sales Price (USD/Dose) Trend (2013-2018)
Table Japan Nano-drug Sales Volume (K Doses) by Players (2013-2018)
Table Japan Nano-drug Sales Volume Market Share by Players (2013-2018)
Figure Japan Nano-drug Sales Volume Market Share by Players in 2017
Table Japan Nano-drug Sales Volume (K Doses) by Type (2013-2018)
Table Japan Nano-drug Sales Volume Market Share by Type (2013-2018)
Figure Japan Nano-drug Sales Volume Market Share by Type in 2017
Table Japan Nano-drug Sales Volume (K Doses) by Application (2013-2018)
Table Japan Nano-drug Sales Volume Market Share by Application (2013-2018)
Figure Japan Nano-drug Sales Volume Market Share by Application in 2017
Figure Southeast Asia Nano-drug Sales (K Doses) and Growth Rate (2013-2018)
Figure Southeast Asia Nano-drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Nano-drug Sales Price (USD/Dose) Trend (2013-2018)
Table Southeast Asia Nano-drug Sales Volume (K Doses) by Players (2013-2018)
Table Southeast Asia Nano-drug Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Nano-drug Sales Volume Market Share by Players in 2017
Table Southeast Asia Nano-drug Sales Volume (K Doses) by Type (2013-2018)
Table Southeast Asia Nano-drug Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Nano-drug Sales Volume Market Share by Type in 2017
Table Southeast Asia Nano-drug Sales Volume (K Doses) by Application (2013-2018)
Table Southeast Asia Nano-drug Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Nano-drug Sales Volume Market Share by Application in 2017
Figure India Nano-drug Sales (K Doses) and Growth Rate (2013-2018)
Figure India Nano-drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Nano-drug Sales Price (USD/Dose) Trend (2013-2018)
Table India Nano-drug Sales Volume (K Doses) by Players (2013-2018)
Table India Nano-drug Sales Volume Market Share by Players (2013-2018)
Figure India Nano-drug Sales Volume Market Share by Players in 2017
Table India Nano-drug Sales Volume (K Doses) by Type (2013-2018)
Table India Nano-drug Sales Volume Market Share by Type (2013-2018)
Figure India Nano-drug Sales Volume Market Share by Type in 2017
Table India Nano-drug Sales Volume (K Doses) by Application (2013-2018)
Table India Nano-drug Sales Volume Market Share by Application (2013-2018)
Figure India Nano-drug Sales Volume Market Share by Application in 2017
Table Merck Basic Information List
Table Merck Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Merck Nano-drug Sales Growth Rate (2013-2018)
Figure Merck Nano-drug Sales Global Market Share (2013-2018)
Figure Merck Nano-drug Revenue Global Market Share (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Pfizer Nano-drug Sales Growth Rate (2013-2018)
Figure Pfizer Nano-drug Sales Global Market Share (2013-2018)
Figure Pfizer Nano-drug Revenue Global Market Share (2013-2018)
Table Novartis Basic Information List
Table Novartis Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Novartis Nano-drug Sales Growth Rate (2013-2018)
Figure Novartis Nano-drug Sales Global Market Share (2013-2018
Figure Novartis Nano-drug Revenue Global Market Share (2013-2018)
Table Abbott Basic Information List
Table Abbott Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Abbott Nano-drug Sales Growth Rate (2013-2018)
Figure Abbott Nano-drug Sales Global Market Share (2013-2018)
Figure Abbott Nano-drug Revenue Global Market Share (2013-2018)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure GlaxoSmithKline Nano-drug Sales Growth Rate (2013-2018)
Figure GlaxoSmithKline Nano-drug Sales Global Market Share (2013-2018)
Figure GlaxoSmithKline Nano-drug Revenue Global Market Share (2013-2018)
Table Roche Basic Information List
Table Roche Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Roche Nano-drug Sales Growth Rate (2013-2018)
Figure Roche Nano-drug Sales Global Market Share (2013-2018
Figure Roche Nano-drug Revenue Global Market Share (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Sanofi Nano-drug Sales Growth Rate (2013-2018)
Figure Sanofi Nano-drug Sales Global Market Share (2013-2018)
Figure Sanofi Nano-drug Revenue Global Market Share (2013-2018)
Table Eli Lilly Basic Information List
Table Eli Lilly Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Eli Lilly Nano-drug Sales Growth Rate (2013-2018)
Figure Eli Lilly Nano-drug Sales Global Market Share (2013-2018
Figure Eli Lilly Nano-drug Revenue Global Market Share (2013-2018)
Table Astrazeneca Basic Information List
Table Astrazeneca Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Astrazeneca Nano-drug Sales Growth Rate (2013-2018)
Figure Astrazeneca Nano-drug Sales Global Market Share (2013-2018)
Figure Astrazeneca Nano-drug Revenue Global Market Share (2013-2018)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Johnson & Johnson Nano-drug Sales Growth Rate (2013-2018)
Figure Johnson & Johnson Nano-drug Sales Global Market Share (2013-2018)
Figure Johnson & Johnson Nano-drug Revenue Global Market Share (2013-2018)
Table Celgene Basic Information List
Table Novavax Basic Information List
Table Stryker Basic Information List
Table Gilead Sciences Basic Information List
Table OSI Pharmaceuticals Basic Information List
Table Kadmon Pharmaceuticals Basic Information List
Table Samyang Biopharm Basic Information List
Table Mitsubishi Pharma Basic Information List
Table Kaken Pharmaceutical Basic Information List
Table Selecta Biosciences Basic Information List
Table Par Pharmaceutical Basic Information List
Table Cerulean Pharma Basic Information List
Table Navidea Biopharmaceuticals Basic Information List
Table Lummy Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nano-drug
Figure Manufacturing Process Analysis of Nano-drug
Figure Nano-drug Industrial Chain Analysis
Table Raw Materials Sources of Nano-drug Major Players in 2017
Table Major Buyers of Nano-drug
Table Distributors/Traders List
Figure Global Nano-drug Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure Global Nano-drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Nano-drug Price (USD/Dose) and Trend Forecast (2018-2025)
Table Global Nano-drug Sales Volume (K Doses) Forecast by Regions (2018-2025)
Figure Global Nano-drug Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Nano-drug Sales Volume Market Share Forecast by Regions in 2025
Table Global Nano-drug Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Nano-drug Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Nano-drug Revenue Market Share Forecast by Regions in 2025
Figure United States Nano-drug Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure United States Nano-drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Nano-drug Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure Europe Nano-drug Revenue and Growth Rate Forecast (2018-2025)
Figure China Nano-drug Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure China Nano-drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Nano-drug Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure Japan Nano-drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Nano-drug Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Nano-drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Nano-drug Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure India Nano-drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Nano-drug Sales (K Doses) Forecast by Type (2018-2025)
Figure Global Nano-drug Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Nano-drug Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Nano-drug Revenue Market Share Forecast by Type (2018-2025)
Table Global Nano-drug Price (USD/Dose) Forecast by Type (2018-2025)
Table Global Nano-drug Sales (K Doses) Forecast by Application (2018-2025)
Figure Global Nano-drug Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Myelodysplastic Syndrome Market Insights, Forecast to 2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 128
    Myelodysplastic syndromes (MDS) are a group of cancers in which immature blood cells in the bone marrow do not mature and therefore do not become healthy blood cells.[2] Early on there are typically no symptoms.Later symptoms may include feeling tired, shortness of breath, easy bleeding, or frequent infections.[2] Some types may develop into acute myeloid leukemia. The presence of diagnostic tools is the key driver for the growth of this market. Diagnosis techniques like blood count, peri......
  • Global Myasthenia Gravis Drugs Market Insights, Forecast to 2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 120
    Acetylcholine esterase (AChE) inhibitors are considered to be the basic treatment of myasthenia gravis (MG). Edrophonium is primarily used as a diagnostic tool owing to its short half-life. Pyridostigmine is used for long-term maintenance. The market is witnessing the rapid development of novel drugs such as monoclonal antibodies, which is one of the primary factors driving this market's growth prospects. Most drug manufacturers are increasingly focussing on the development of monoclonal ......
  • Global MRSA Drugs Market Insights, Forecast to 2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 122
    Staphylococcus aureus is a bacteria commonly found on nose or skin of healthy people. MRSA i.e., methicillin-resistant staphylococcus aureus, is thus a type of staphylococcus aureus that is resistant to beta-lactam antibiotic called methicillin. MRSA strains do not respond to methicillin treatment. Around 1% of the population carrying staphylococcus aureus on their nose or skin are infected by MRSA. The infection causes skin and tissue infection, and is transmitted by direct skin-to-skin contact......
  • Global Fibrin Sealants Market Insights, Forecast to 2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 125
    Fibrin sealant, a two-component substance consisting of thrombin and fibrinogen, is used as a hemostatic or adhesive in various surgical solutions. In clinical practice, a fibrin sealant consists of a concentrated solution of fibrinogen and Factor XIII, which combine with a solution of calcium and thrombin to form a coagulum that stimulates clotting. Beriplast P and TISSEEL are some of the commercially available fibrin sealants. The Americas accounted for 48% of the market share during th......
  • Global Female Contraceptive Market Insights, Forecast to 2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 110
    Female contraceptives, also known as female birth control are methods of preventing pregnancy that primarily involve the female physiology. Female contraceptive devices account for major shares of the contraceptive pills market throughout the forecast period. The increasing adoption of female contraceptive devices will drive the growth of this product segment in the female contraceptive market. The Americas will be the major revenue contributor to the contraceptive pills market thr......
  • Global Female Condoms Market Insights, Forecast to 2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 114
    A female condom is a birth control device that acts as a barrier to prevent sexual fluids from entering the vagina during intercourse. It protects against pregnancy and sexually transmitted infections (STIs). The online stores will be the fastest-growing segment and will continue to maintain its lead in the global market. Much of the segment's growth is due to its higher penetration rate and adoptability. Female condoms are easily accessible online and allow for useful comparison in terms......
  • Global Excipients Market Insights, Forecast to 2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 111
    Excipients are inert substances that are generally used to manufacture different forms of drugs and are present in the finished products. Excipients help in providing long-term stability and make solid formulations bulkier. They also improve the functionality of drugs and make them safer. Based on functionality, the pharmaceutical excipients market is segmented into fillers & diluents, binders, suspending & viscosity agents, flavoring agents & sweeteners, coating agents, colorants, disint......
  • Global Consumer Healthcare Market Insights, Forecast to 2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 127
    Consumer healthcare products include trusted brands of multivitamins and iron supplements, in addition to products for allergies, personal hygiene, sleep support, alertness and cold and flu. Consumer health products do not require a written prescription from healthcare professionals but can be purchased directly from a pharmacy store. The global Consumer Healthcare market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx%......
  • Global Intravenous (IV) Ibuprofen Market Insights, Forecast to 2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 114
    Intravenous (IV) ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to reduce or treat pain, fever, and inflammation occurred due to a disease, operative procedures or trauma, and acute illness. The global Intravenous (IV) Ibuprofen market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Intravenous (IV) Ibuprofen ma......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs